Clinical Trials Browser

Phase 2 × Unknown × Metastatic Castration-resistant Prostate Cancer × Clear all

NCT05955209 2023-07-21

Clinical Study on the Efficacy and Safety of RC48-ADC in the Treatment of Metastatic Castration Resistant Prostate Cancer (mCRPC)

Phase 2 Unknown

Metastatic Castration-resistant Prostate Cancer

NCT05327621 2022-04-14

Pamiparib in mCRPC With HRD or BRCA1/2 Mutation

Phase 2 Unknown

Metastatic Castration-resistant Prostate Cancer

NCT04586543 2020-10-14

Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma

Phase 2 Unknown

Metastatic Castration-resistant Prostate Cancer